Get started
Author

Ryo Matsuyama

Observed name: R. Matsuyama
ORCID: 0000-0003-1483-4746
Observed ORCID: 0000-0003-1483-4746
OpenAlex ID: A5090773990
Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
2020 · Ryota Nakajima, Hiroyuki Oono, et al. · ACS Medicinal Chemistry Letters · 28
Stabilization and quantitative measurement of nicotinamide adenine dinucleotide in human whole blood using dried blood spot sampling
2022 · Ryo Matsuyama, Tomoyo Omata, et al. · Analytical and Bioanalytical Chemistry · 16
PDF
Metabolite alteration analysis of acetaminophen-induced liver injury using a mass microscope
2022 · Ryo Matsuyama, Yuki Okada, et al. · Analytical and Bioanalytical Chemistry · 7
Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery
2024 · Hiroaki Fujita, Taiichi Wakiya, et al. · Scientific Reports · 4
Association Between the Development of Sensorineural Hearing Loss and Blood NAD+ Levels
2024 · Hideaki Sakata, Ken Hayashi, et al. · Journal of Clinical Medicine Research · 3
PDF
1051 Pharmacological profile of TEI-R1, an oral inverse agonist of RORγt as a drug candidate for psoriasis
2018 · A. Makino, A. Baba, et al. · Journal of Investigative Dermatology
Works count: 6
Citation count: 58
H-index: 4
I10-index: 2
Year
Topic
Type